Literature DB >> 21939638

Increased susceptibility to Candida infection following cecal ligation and puncture.

Christopher G Davis1, Kathy Chang, Dale Osborne, Andrew H Walton, W Michael Dunne, Jared T Muenzer.   

Abstract

Secondary infection following septic insult represents a significant cause of morbidity and mortality in hospitalized patients. Sepsis induced immunosuppression is a major factor in the host's susceptibility to nosocomial infections and Candida albicans accounts for a growing number of these. Given the importance of improving our understanding of the immune response to sepsis and the increasing rates of C. albicans infections, we sought to develop a murine model of double injury consisting of primary peritonitis, i.e., cecal ligation and puncture (CLP), followed by a secondary challenge of C. albicans. As observed in previous work, after primary injury the immune profile of the host changes over time. Therefore, while keeping the mortality rates from the respective individual injuries low, we altered the timing of the secondary injury between two post-CLP time points, day two and day four. Mice subjected to C. albicans infection following CLP have significantly different survival rates dependent upon timing of secondary injury. Animals challenged with C. albicans at two days post CLP had 91% mortality whereas animals challenged at four days had 47% mortality. This improvement in survival at four days was associated with restoration of innate cell populations and as evidenced by stimulated splenocytes, increases in certain inflammatory cytokines. In addition, we show that susceptibility to C. albicans infection following CLP is dependent upon the depth of immunosuppression. Although at four days post-CLP there is a partial reconstitution of the immune system, these animals remain more susceptible to infection compared to their single injury (C. albicans alone) counterparts. Collectively, these studies demonstrate that immunosuppression following initial septic insult changes over time. This novel, two hit model of CLP followed by Candida provides additional insight into the immune compromised state created by primary peritonitis, and thereby opens up another avenue of investigation into the causes and possible cures of an emerging clinical problem.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939638      PMCID: PMC3195872          DOI: 10.1016/j.bbrc.2011.09.017

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Selective defects of T lymphocyte function in patients with lethal intraabdominal infection.

Authors:  C D Heidecke; T Hensler; H Weighardt; N Zantl; H Wagner; J R Siewert; B Holzmann
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

4.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 5.  Pathogenesis of invasive candidiasis.

Authors:  Frank L van de Veerdonk; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Opin Crit Care       Date:  2010-10       Impact factor: 3.687

6.  Attributable mortality of nosocomial candidemia, revisited.

Authors:  Olafur Gudlaugsson; Shane Gillespie; Kathleen Lee; Jeff Vande Berg; Jianfang Hu; Shawn Messer; Loreen Herwaldt; Michael Pfaller; Daniel Diekema
Journal:  Clin Infect Dis       Date:  2003-10-08       Impact factor: 9.079

7.  Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.

Authors:  Yona Kalechman; Uzi Gafter; Rivka Gal; Galit Rushkin; Donghong Yan; Michael Albeck; Benjamin Sredni
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Effect of sepsis on tissue adenine nucleotide levels.

Authors:  I H Chaudry; K A Wichterman; A E Baue
Journal:  Surgery       Date:  1979-02       Impact factor: 3.982

9.  Innate versus adaptive immunity in Candida albicans infection.

Authors:  Robert B Ashman; Camile S Farah; Siripen Wanasaengsakul; Yan Hu; Gerald Pang; Robert L Clancy
Journal:  Immunol Cell Biol       Date:  2004-04       Impact factor: 5.126

10.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

View more
  18 in total

1.  Distinct Effects of Integrins αXβ2 and αMβ2 on Leukocyte Subpopulations during Inflammation and Antimicrobial Responses.

Authors:  Samir Jawhara; Elzbieta Pluskota; Wei Cao; Edward F Plow; Dmitry A Soloviev
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

2.  Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.

Authors:  Yuichiro Shindo; Jacqueline Unsinger; Cary-Ann Burnham; Jonathan M Green; Richard S Hotchkiss
Journal:  Shock       Date:  2015-04       Impact factor: 3.454

3.  High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse.

Authors:  Asada Leelahavanichkul; Poorichaya Somparn; Tanabodee Bootprapan; Hongbin Tu; Pattarin Tangtanatakul; Ratchanok Nuengjumnong; Navaporn Worasilchai; Khajohn Tiranathanagul; Somchai Eiam-ong; Mark Levine; Ariya Chinampon; Nattachai Srisawat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-01       Impact factor: 3.619

4.  Anti-PD-L1 peptide improves survival in sepsis.

Authors:  Yuichiro Shindo; Jacquelyn S McDonough; Katherine C Chang; Murali Ramachandra; Pottayil G Sasikumar; Richard S Hotchkiss
Journal:  J Surg Res       Date:  2016-09-08       Impact factor: 2.192

5.  Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.

Authors:  Stephanie A Condotta; Shaniya H Khan; Deepa Rai; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

6.  Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection.

Authors:  Stephanie A Condotta; Deepa Rai; Britnie R James; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

7.  Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions.

Authors:  Sean Duong; Stephanie A Condotta; Deepa Rai; Matthew D Martin; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

8.  Severe sepsis facilitates intestinal colonization by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and transfer of the SHV-18 resistance gene to Escherichia coli during antimicrobial treatment.

Authors:  Jun Guan; Shaoze Liu; Zhaofen Lin; Wenfang Li; Xuefeng Liu; Dechang Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

9.  Mechanical Ventilation Induces an Inflammatory Response in Preinjured Lungs in Late Phase of Sepsis.

Authors:  Wei Xuan; Quanjun Zhou; Shanglong Yao; Qingzhu Deng; Tingting Wang; Qingping Wu
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

Review 10.  Sepsis induced immunosuppression: Implications for secondary infections and complications.

Authors:  Krishna M Sundar; Mazen Sires
Journal:  Indian J Crit Care Med       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.